These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30276573)

  • 1. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
    Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
    Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.
    Mori R; Futamura M; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K; Yoshida K
    Oncol Lett; 2017 Sep; 14(3):3162-3168. PubMed ID: 28927061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
    Mori R; Ukai J; Tokumaru Y; Niwa Y; Futamura M
    Oncol Lett; 2022 Sep; 24(3):311. PubMed ID: 35949616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line.
    Tsutani Y; Yoshida K; Sanada Y; Wada Y; Konishi K; Fukushima M; Okada M
    Oncol Rep; 2008 Dec; 20(6):1545-51. PubMed ID: 19020740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.
    Chung YM; Park S; Park JK; Kim Y; Kang Y; Yoo YD
    Cancer Lett; 2000 Oct; 159(1):95-101. PubMed ID: 10974411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.
    Matsuoka K; Nakagawa F; Kobunai T; Takechi T
    Oncotarget; 2018 Mar; 9(17):13438-13450. PubMed ID: 29568368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells.
    Mori R; Yoshida K; Tanahashi T; Yawata K; Kato J; Okumura N; Tsutani Y; Okada M; Oue N; Yasui W
    Gastric Cancer; 2013 Jul; 16(3):345-54. PubMed ID: 22968820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
    Inaba M; Mitsuhashi J; Sawada H; Miike N; Naoe Y; Daimon A; Koizumi K; Tsujimoto H; Fukushima M
    Jpn J Cancer Res; 1996 Feb; 87(2):212-20. PubMed ID: 8609072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
    Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K
    Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.
    de Bruin M; van Capel T; Van der Born K; Kruyt FA; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
    Br J Cancer; 2003 Mar; 88(6):957-64. PubMed ID: 12644837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
    Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
    Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
    Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
    Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells.
    Temmink OH; de Bruin M; Laan AC; Turksma AW; Cricca S; Masterson AJ; Noordhuis P; Peters GJ
    Int J Biochem Cell Biol; 2006; 38(10):1759-65. PubMed ID: 16798057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.